Journal · Diabetes · Updated 21 November 2026
Acta Diabetologica
Read Acta Diabetologica articles on DeepDyve. No university library needed.
Acta Diabetologica covers diabetes and its complications, from drug treatment and heart and kidney protection to diabetic foot disease and oral health. Springer Nature publishes it. It was previously published as Acta Diabetologica Latina. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Acta Diabetologica at a glance
- Full title
- Acta Diabetologica
- Former title
- Acta Diabetologica Latina
- Abbreviation (NLM)
- Acta Diabetol
- Publisher
- Springer Nature
- Print ISSN
- 0940-5429
- Online ISSN (eISSN)
- 1432-5233
- Current title since
- 1991
- Subjects
- Endocrinology
- Access model
- Hybrid (29% free to read in 2026)
Ways to access Acta Diabetologica
29% of the articles Acta Diabetologica published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 29% of Acta Diabetologica articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Acta Diabetologica. Check its journal list and whether it offers remote access.
- DeepDyve. Read Acta Diabetologica articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Acta Diabetologica’s 2025 Journal Impact Factor is 3.1, and its 5-year Impact Factor is 3.2.
3.1
Journal Impact Factor (2025)
3.2
5-year Impact Factor (2025)
8 days
Median time to first decision
Source: journal metrics on the Acta Diabetologica homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Acta Diabetologica research worth reading
Published January to February 2026. Summaries describe what the authors report.
-
Periodontitis and diabetes: a bidirectional link
The authors review the two-way link between periodontitis and diabetes, in which diabetes worsens gum disease and periodontitis can impair glycemic control, and argue that periodontitis is underdiagnosed in diabetes care and calls for medical and dental collaboration.
Nguyen et al. · Acta Diabetologica, published online February 2, 2026 · DOI 10.1007/s00592-026-02642-3
-
Continuous glucose monitoring versus self-monitoring of blood glucose in gestational diabetes: an updated systematic review and meta-analysis of randomized controlled trials
Pooling 11 randomized trials with 1,225 women with gestational diabetes, Gautam and colleagues report that continuous glucose monitoring, compared with self-monitoring, raised the likelihood of appropriate maternal weight gain and lowered birth weight by 122.79 g, but did not improve overall glycemic control.
Gautam et al. · Acta Diabetologica, published online January 27, 2026 · DOI 10.1007/s00592-026-02644-1
-
Integrative analysis of placental metabolic reprogramming and microbiome alterations in gestational diabetes mellitus (GDM)
Yousefi and colleagues review how the placenta reprograms lipid, amino acid and glucose metabolism in gestational diabetes, and how gut microbial imbalances, with fewer Bifidobacterium, Akkermansia and Roseburia, influence endocrine signaling and immune function and can pass to the newborn.
Yousefi et al. · Acta Diabetologica, published online January 8, 2026 · DOI 10.1007/s00592-025-02638-5
-
Therapeutic role of gut microbial metabolite indole propionic acid in a rat model of high-fat diet/Streptozotocin-Induced diabetes: enhancing glucose metabolism, antioxidant defense and PI3K/Akt/GLUT4 signaling pathway
In a rat model of streptozotocin-induced diabetes, Shuja and colleagues report that four weeks of oral indole propionic acid lowered fasting blood glucose, preserved pancreatic islet architecture, boosted antioxidant enzyme activity and raised PI3K, Akt and GLUT4 expression in skeletal muscle.
Shuja et al. · Acta Diabetologica, published online February 18, 2026 · DOI 10.1007/s00592-026-02652-1
-
Efficacy and safety of orforglipron in type 2 diabetes mellitus and obesity: a GRADE-assessed meta-analysis and trial sequential analysis with subgroup evaluations by diabetic status, obesity status, and dose regimens
Pooling five placebo-controlled trials with 2,672 adults, Jamal and colleagues report that the oral GLP-1 receptor agonist orforglipron lowered HbA1c, body weight, BMI and systolic blood pressure, raised heart rate, and did not increase hypoglycemia or serious adverse events.
Jamal et al. · Acta Diabetologica, published online January 7, 2026 · DOI 10.1007/s00592-025-02635-8
Related journals
Questions about Acta Diabetologica
How can I read Acta Diabetologica articles without a subscription?
29% of Acta Diabetologica articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Acta Diabetologica articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Acta Diabetologica?
Acta Diabetologica’s NLM (PubMed) abbreviation is Acta Diabetol.
What is the ISSN of Acta Diabetologica?
The print ISSN is 0940-5429 and the online ISSN is 1432-5233.
What is the impact factor of Acta Diabetologica?
Acta Diabetologica’s Journal Impact Factor is 3.1 (2025), and its 5-year Impact Factor is 3.2, according to Springer Nature’s published metrics.
Is Acta Diabetologica open access?
Acta Diabetologica is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 53 of 185 Acta Diabetologica articles (29%) carry a Creative Commons license, per Crossref.
Acta Diabetologica articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Acta Diabetologica today
One month free, then less than $2 a day. Acta Diabetologica, plus millions of articles from thousands of journals.





